AVANIR Pharmaceuticals Balance Sheet
View: Annual | Quarterly
| Assets | Sep 08 | Sep 07 | Sep 06 |
|---|---|---|---|
| Current Assets | |||
| Cash | 41.4 | 30.5 | 4.9 |
| Net Receivables | 0.0 | 1.0 | 3.0 |
| Inventories | 0.0 | 0.0 | 2.8 |
| Other Current Assets | 1.7 | 3.9 | 18.6 |
| Total Current Assets | 43.1 | 35.4 | 29.3 |
| Net Fixed Assets | 0.8 | 1.2 | 6.0 |
| Other Noncurrent Assets | 2.0 | 2.5 | 36.1 |
| Total Assets | 45.9 | 39.1 | 71.5 |
| Liabilities and Shareholder's Equity | Sep 08 | Sep 07 | Sep 06 |
| Current Liabilities | |||
| Accounts Payable | 0.5 | 0.3 | 10.8 |
| Short-Term Debt | 0.0 | 2.5 | 0.9 |
| Other Current Liabilities | 5.4 | 3.2 | 24.6 |
| Total Current Liabilities | 5.9 | 6.1 | 36.3 |
| Long-Term Debt | 0.0 | 11.8 | 24.9 |
| Other Noncurrent Liabilities | 11.0 | 14.2 | 15.9 |
| Total Liabilities | 16.9 | 32.1 | 77.1 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | 29.0 | 7.0 | (5.7) |
| Total Equity | 29.0 | 7.0 | (5.7) |
| Shares Outstanding (mil.) | 78.5 | 78.5 | 78.5 |
© 2009 Morningstar, Inc. Financial Data provided by
